Peptide Library
23 peptides
A synthetic peptide derived from human gastric juice protein, widely used for tissue repair and gut health.
A fragment of Thymosin Beta-4 that promotes systemic tissue repair, cell migration, and deep healing.
A long-acting growth hormone-releasing hormone (GHRH) analog that sustains elevated GH and IGF-1 levels.
A selective growth hormone secretagogue that creates targeted GH pulses with minimal impact on cortisol or ACTH.
An oral GH secretagogue that significantly elevates GH and IGF-1, improving muscle mass, sleep architecture, and recovery.
An FDA-approved GLP-1 receptor agonist with the strongest clinical evidence for weight loss of any peptide — 15–18% body weight reduction in trials.
A dual GLP-1/GIP receptor agonist showing even greater weight loss than semaglutide in head-to-head trials.
A naturally occurring copper-binding peptide with the broadest independently replicated evidence for skin, tissue repair, and systemic anti-aging.
A tetrapeptide derived from the pineal gland with the strongest evidence for telomere biology and cellular longevity.
The strongest clinically validated immune-modulating peptide, approved in 30+ countries for viral infections and immune deficiency.
A natural antimicrobial peptide that protects against bacterial, viral, and fungal infections while modulating inflammation.
A potent anti-inflammatory tripeptide derived from alpha-MSH, effective for gut inflammation and immune over-activation.
A neuropeptide developed in Russia with strong nootropic, neuroprotective, and focus-enhancing properties.
A synthetic analog of the immune peptide tuftsin with anxiolytic and nootropic effects — often called 'anxiety relief without sedation.'
An extremely potent nootropic peptide — reported to be millions of times more potent than BDNF at forming new synaptic connections.
A mitochondria-derived peptide that regulates metabolic homeostasis, exercise response, and systemic aging.
A modified IGF-1 analog with a longer half-life that drives rapid muscle hypertrophy and nutrient partitioning.
A modified fragment of human growth hormone that stimulates fat breakdown without the growth-promoting effects of full HGH.
An FDA-approved GHRH analog originally for HIV-related lipodystrophy, now widely used for visceral fat reduction and body composition.
An FDA-approved melanocortin receptor agonist for hypoactive sexual desire disorder — works centrally on the brain, not the vascular system.
The oldest and best-established GHRH analog with the longest clinical track record and a historical FDA approval for pediatric GH deficiency.
The fat-burning fragment of HGH that stimulates lipolysis without growth-promoting or blood sugar effects.
A neuropeptide mixture derived from pig brain protein with strong clinical evidence for neuroprotection and cognitive restoration, approved in many countries.